PAPER Morrow CB, Kamath V, Dickerson BC, Eldaief M, Rezaii N, Wong B, McGinnis S, Darby R, Staffaroni AM, Lapid MI, Pascual B, Rojas JC, Masdeu JC, Tsapkini K, Huey ED, Fisher DW, Pantelyat A, Balaji A, Sah E, Litvan I, Rascovsky K, Ghoshal N, Domoto-Reilly K, Kornak J, Onyike CU, ALLFTD Consortium
SEARCH RESULTS
1791 RESULTS
PAPER Kakino Y, Hattori Y, Ogata S, Nakaoku Y, Nishimura K, Iida H, Ihara M
Cerebral Hemodynamic Impairment and Cognitive Dysfunction in APOE4 Carriers With Asymptomatic Carotid Artery Stenosis/Occlusion.
J Am Heart Assoc. 2025 Mar 13;:e039210. Epub 2025 Mar 13 PubMed.PAPER Pang S, Li Z, Liu A, Luo ZH, Yin H, Fan S, Shi J, Liu N, Pan S, Yang YJ, Zhang GJ, Chen J
A Novel Oxo-Palmatine Derivative 2q as Potent Reversal Agents Against Alzheimer's Disease.
Drug Dev Res. 2025 Apr;86(2):e70073. PubMed.PAPER Songhori N, Goushky MS, Khaleghi MM, Mojerloo M, Sadeghi M, Mozafar M, Aghdam ZB, Ghajar M, Kianifar Y, Karimzadeh F, Khosravi F, Mayeli M
Growth-Associated Protein 43 Levels in the Cerebrospinal Fluid Correspond to the Cerebral Blood Flow Alterations in Alzheimer's Dementia Continuum: An Original Study.
Health Sci Rep. 2025 Mar;8(3):e70534. Epub 2025 Mar 11 PubMed.PAPER Reyes-Pablo AE, Luna-Viramontes NI, Montiel-Sosa JF, Ontiveros-Torres MÁ, Garcés-Ramírez L, de la Cruz-López F, Apátiga-Pérez R, Villanueva-Fierro I, Hernandes-Alejandro M, Jaramillo-Loranca BE, Vargas-Hernández G, Pacheco-Herrero M, Luna-Muñoz J
Vulnerability of the entorhinal cortex II to neurodegeneration in Alzheimer's disease.
Brain Commun. 2025;7(2):fcaf091. Epub 2025 Feb 26 PubMed.PAPER Abbott V, Housden BE, Houldsworth A
Could immunotherapy and regulatory T cells be used therapeutically to slow the progression of Alzheimer's disease?
Brain Commun. 2025;7(2):fcaf092. Epub 2025 Feb 25 PubMed.PAPER Yu X, Zhu K, Wang T, Li HY, Zhang X, Zhong X, Wang L
The Correlation Between RIN3 Gene Methylation and Cognitive Impairment in Parkinson's Disease.
Neuropsychiatr Dis Treat. 2025;21:511-524. Epub 2025 Mar 7 PubMed.PAPER Salemme S, Lombardo FL, Lacorte E, Sciancalepore F, Remoli G, Bacigalupo I, Piscopo P, Zamboni G, Rossini PM, Cappa SF, Perani D, Spadin P, Tagliavini F, Vanacore N, Ancidoni A
The prognosis of mild cognitive impairment: A systematic review and meta-analysis.
Alzheimers Dement (Amst). 2025;17(1):e70074. Epub 2025 Mar 12 PubMed.PAPER Guo H, Yang R, Cheng W, Li Q, Du M
An Update of Salivary Biomarkers for the Diagnosis of Alzheimer's Disease.
Int J Mol Sci. 2025 Feb 26;26(5) PubMed.PAPER Michielsen A, van Veenhuijzen K, Hiemstra F, Jansen IM, Kalkhoven B, Veldink JH, Kruitwagen ET, van Es M, van Zandvoort MJ, van den Berg LH, Westeneng HJ
Cognitive impairment within and beyond the FTD spectrum in ALS: development of a complementary cognitive screen.
J Neurol. 2025 Mar 13;272(4):268. PubMed.PAPER Alves L, Hashiguchi D, Loss CM, van Praag H, Longo BM
Vascular dysfunction in Alzheimer's disease: Exploring the potential of aerobic and resistance exercises as therapeutic strategies.
J Alzheimers Dis. 2025 Mar 13;:13872877251321118. Epub 2025 Mar 13 PubMed.PAPER Nie P, Wu Y, Robinson J, Mekala S, Lee VM, Li YM
In Situ Labeling of Pathogenic Tau Using Photo-Affinity Chemical Probes.
ACS Chem Biol. 2025 Mar 13; Epub 2025 Mar 13 PubMed.PAPER Zhu Q, Deng YL, Liu Y, Steenland K
Associations between Ultrafine Particles and Incident Dementia in Older Adults.
Environ Sci Technol. 2025 Mar 13; Epub 2025 Mar 13 PubMed.PAPER Frydas A, Cacace R, van der Zee J, Van Broeckhoven C, Wauters E
Investigation of the role of miRNA variants in neurodegenerative brain diseases.
Front Genet. 2025;16:1506169. Epub 2025 Feb 26 PubMed.PAPER Gupta C, Kim C, Guzy S, Yoneyama T, Gharahi H, Siripuram VK, Iadevaia S, Barua D, Hang Y, Iakovleva T, Boucher C, Vakilynejad M, Schmidt S, Vozmediano V
Establishment of a Biomarker-Directed Clinical Endpoint Model for Early-Stage Parkinson's Disease Patients.
Clin Pharmacol Ther. 2025 Mar 12; Epub 2025 Mar 12 PubMed.Current Filters
- Date Range : Past 30 Days x